July 24, 2014 3:37 AM ET

Pharmaceuticals

Company Overview of New Haven Pharmaceuticals, Inc.

Company Overview

New Haven Pharmaceuticals, Inc. develops prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe active pharmaceutical ingredients for therapeutic applications. It offers NHP-554C, an anti-platelet aspirin product for patients at higher risk for a secondary stroke/acute cardiac event that slowly releases into the bloodstream over 24 hours; NHP-554CZ, an anti-platelet aspirin product incorporating Yale University technology utilizing zinc salts; and NHP-229 for the purpose of lowering stomach acid alone or in combination with other drugs. The company was founded in 2008 and is based in New Haven, Connecticut.

142 Temple Street

Suite 205

New Haven, CT 06510

United States

Founded in 2008

Key Executives for New Haven Pharmaceuticals, Inc.

Chief Executive Officer
Age: 66
Co-Founder and Executive Chairman
Age: 69
Executive Vice President of Operations and Director
Age: 50
Vice President of Regulatory Affairs
Age: 61
Compensation as of Fiscal Year 2014.

New Haven Pharmaceuticals, Inc. Key Developments

New Haven Pharmaceuticals, Inc. Appoints Larry Dillaha as Executive Vice President Operations

New Haven Pharmaceuticals, Inc. announced the appointment of Larry Dillaha, M.D., to the newly-created position of Executive Vice President Operations. Dr. Dillaha joins the company from Insys Therapeutics, Inc. where he served as Chief Medical Officer since April 2010. Prior to joining New Haven Pharmaceuticals, Dr. Dillaha served as Chief Medical Officer of Insys Therapeutics.

Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals

Horizon Technology Finance Corporation announced it has closed a $2 million venture loan facility with New Haven Pharmaceuticals, Inc. The proceeds of the venture loan facility will be used for working capital purposes.

Similar Private Companies By Industry

Company Name Region
Janssen Pharmaceuticals, Inc. United States
CEPH International Corp. United States
JSK Therapeutics, Inc. United States
InnoRem, Inc. United States
Fulcrum Pharma Developments, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 30, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact New Haven Pharmaceuticals, Inc., please visit www.newhavenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.